Showing results (71-80 of 223) with videos related to

Sort By:
Pageof 23
Journal of Occupational and Environmental Medicine|January 1, 2010
Employment and work impact of chronic migraine and episodic migraineWalter F Stewart, G Craig Wood, Aubrey Manack, et al.
Headache|November 20, 2015
Asthma is a risk factor for new onset chronic migraine: Results from the American migraine prevalence and prevention studyVincent T Martin, Kristina M Fanning, Daniel Serrano, et al.
Headache|January 23, 2016
Perimenopause and Menopause Are Associated With High Frequency Headache in Women With Migraine: Results of the American Migraine Prevalence and Prevention StudyVincent T Martin, Jelena Pavlovic, Kristina M Fanning, et al.
Neurology|December 26, 2014
Recalled maltreatment, migraine, and tension-type headache: results of the AMPP studyGretchen E Tietjen, Dawn C Buse, Kristina M Fanning, et al.
Health and Quality of Life Outcomes|October 8, 2016
Measuring the impact of migraine for evaluating outcomes of preventive treatments for migraine headachesSally Mannix, Anne Skalicky, Dawn C Buse, et al.
Frontiers in Neurology|June 22, 2026
Evaluating the relationship between the 4-item migraine interictal burden scale and other patient-reported outcome measures: a post hoc analysis from a phase 3 migraine prevention studyChristian Lampl, Richard B Lipton, Sarah Lipsius, et al.
Headache|November 2, 2022
The unique role of stigma in migraine-related disability and quality of lifeElizabeth K Seng, Robert E Shapiro, Dawn C Buse, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|January 23, 2013
Cost and predictors of lost productive time in chronic migraine and episodic migraine: results from the American Migraine Prevalence and Prevention (AMPP) StudyDaniel Serrano, Aubrey N Manack, Michael L Reed, et al.
Neurology|August 5, 2020
Effect of fremanezumab on quality of life and productivity in patients with chronic migraineRichard B Lipton, Joshua M Cohen, Sanjay K Gandhi, et al.
Headache|September 3, 2013
Impact of NSAID and Triptan use on developing chronic migraine: results from the American Migraine Prevalence and Prevention (AMPP) studyRichard B Lipton, Daniel Serrano, Robert A Nicholson, et al.
Pageof 23